Companies / Germany
Stada To Sell US Facility
July 2006 | FDI AlertGerman generic company Stada Arzneimittel is to sell its unprofitable US unit to local firm DAVA Pharmaceuticals for US$40mn, signalling a disappointing exit from the world's largest generics market.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
